Skip to main content

Table 1 The clinical characteristics of the other 56 patients received allo-HSCT

From: Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation

Characteristics

Total

Number

56

Patient age, median (range) age

31 (8–54)

Patient sex, male, n (%)

31 (55.0%)

Patient/donor HLA incompatibility

 

Related matched

16

Related mis-matched

40

Diagnosis

 

AML,n (%)

29

CML,n (%)

1

B-ALL,n (%)

24

MDS,n (%)

1

BAL,n (%)

1

Disease status

 

High risk

29 (52.0%)

Standard risk

27 (48.0%)

Situation after allo-HSCT

 

No relapse indication

42

MRD+

7

Haematological relapse

5

Extramedullary relapse

2

  1. AML, acute myeloid leukemia; B-ALL, B cell acute lymphoblastic leukemia; CML, chronic myeloid leukemia; MDS, Myelodysplastic syndrome; BAL, biphenotypic acute leukemia.